Literature DB >> 2994048

Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity.

F C Kull, S Jacobs, P Cuatrecasas.   

Abstract

Tumor necrosis factor (TNF) is a proteinaceous toxin shed by stimulated myeloid cells. Murine TNF was radioiodinated to a specific activity of 1 mCi/nmol (1 Ci = 37 GBq) of monomer. 125I-labeled TNF (125I-TNF) retained complete cytotoxic activity and it was immunochemically identical to the native toxin in a quantitative immunoprecipitation assay. It could be shown by competition binding that 125I-TNF bound to intact L929 cells with a specificity equal to that of native toxin. The conditions of time, temperature, and concentration involved in equilibrium specific binding to intact cells were studied in detail. When binding was carried out at 4 degrees C for 18 hr, four cell lines sensitive to 125I-TNF cytotoxicity demonstrated high-affinity binding. The binding reached half-maximal level at 3 pM and saturated at 30 pM. These concentrations approximated those required for cell death. Scatchard analysis gave approximately 1000 sites per cell. J774.1 cells, the source of the toxin, demonstrated similar binding but were not sensitive to 125I-TNF cytotoxicity. Other sensitive cell lines and freshly extracted tumor cells showed specific binding at 3 pM. Normal lymphoid organ cell suspensions and two human tumorigenic cell lines were not sensitive and failed to demonstrate specific binding. 125I-TNF, covalently cross-linked to its receptor on sensitive L-M cells with disuccinimidyl suberate, was isolated and analyzed by sodium dodecyl sulfate/polyacrylamide gel electrophoresis and autoradiography. Two specific bands were identified. The most prominent band had a mobility corresponding to a molecular mass of 95 kDa and the second band had a molecular mass of 75 kDa. The presence of the binding site appears to be necessary but not sufficient to explain the sensitivity of cells to the cytotoxic action of TNF.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994048      PMCID: PMC390631          DOI: 10.1073/pnas.82.17.5756

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Comparison of in vitro cell cytotoxic assays for tumor necrosis factor.

Authors:  D A Flick; G E Gifford
Journal:  J Immunol Methods       Date:  1984-03-30       Impact factor: 2.303

2.  Endotoxin induced 'tumour-necrosis serum' kills a subpopulation of normal lymphocytes in vitro.

Authors:  J H Playfair; J B de Souza; J Taverne
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

3.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Authors:  D Pennica; G E Nedwin; J S Hayflick; P H Seeburg; R Derynck; M A Palladino; W J Kohr; B B Aggarwal; D V Goeddel
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

4.  Estimation of cell number by neutral red content. Applications for proliferative and survival assays.

Authors:  F C Kull; P Cuatrecasas
Journal:  Appl Biochem Biotechnol       Date:  1983-04       Impact factor: 2.926

5.  Chemical crosslinking of the mononuclear phagocyte specific growth factor CSF-1 to its receptor at the cell surface.

Authors:  C J Morgan; E R Stanley
Journal:  Biochem Biophys Res Commun       Date:  1984-02-29       Impact factor: 3.575

6.  Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.

Authors:  B D Williamson; E A Carswell; B Y Rubin; J S Prendergast; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

7.  Human tumor necrosis factor. Production, purification, and characterization.

Authors:  B B Aggarwal; W J Kohr; P E Hass; B Moffat; S A Spencer; W J Henzel; T S Bringman; G E Nedwin; D V Goeddel; R N Harkins
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

8.  Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity.

Authors:  P W Gray; B B Aggarwal; C V Benton; T S Bringman; W J Henzel; J A Jarrett; D W Leung; B Moffat; P Ng; L P Svedersky
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

9.  Necrosin: purification and properties of a cytotoxin derived from a murine macrophage-like cell line.

Authors:  F C Kull; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

10.  Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor.

Authors:  T Shirai; H Yamaguchi; H Ito; C W Todd; R B Wallace
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

View more
  71 in total

Review 1.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Density Gradient Study of Victorin-Binding Proteins in Oat (Avena sativa) Cells.

Authors:  K. Akimitsu; L. P. Hart; J. D. Walton
Journal:  Plant Physiol       Date:  1993-09       Impact factor: 8.340

3.  Tumor necrosis factor expression in human epithelial tumor cell lines.

Authors:  D R Spriggs; K Imamura; C Rodriguez; E Sariban; D W Kufe
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

4.  Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor.

Authors:  S H Socher; M W Riemen; D Martinez; A Friedman; J Tai; J C Quintero; V Garsky; A Oliff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Tumor necrosis factor induces phosphorylation of a 28-kDa mRNA cap-binding protein in human cervical carcinoma cells.

Authors:  M W Marino; L M Pfeffer; P T Guidon; D B Donner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Tumor necrosis factor inhibits MYC expression in HL-60 cells at the level of mRNA transcription.

Authors:  M Krönke; C Schlüter; K Pfizenmaier
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

7.  Tumour necrosis factor, cholestatic jaundice, and chronic liver disease.

Authors:  A Jones; P J Selby; C Viner; S Hobbs; M E Gore; T J McElwain
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

Review 8.  Resistance of tumor cells to tumor necrosis factor.

Authors:  H M Shepard; G D Lewis
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

9.  Human tumor necrosis factor increases the resistance against Listeria infection in mice.

Authors:  K Kato; A Nakane; T Minagawa; N Kasai; K Yamamoto; N Sato; N Tsuruoka
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

10.  Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.

Authors:  M Lewis; L A Tartaglia; A Lee; G L Bennett; G C Rice; G H Wong; E Y Chen; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.